ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 18 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,034 | -39.9% | 8,882 | 0.0% | 0.00% | – |
| Q2 2023 | $23,336 | -40.1% | 8,882 | -17.0% | 0.00% | – |
| Q1 2023 | $38,933 | -15.8% | 10,696 | -8.9% | 0.00% | – |
| Q4 2022 | $46,250 | -39.9% | 11,746 | -34.9% | 0.00% | – |
| Q3 2022 | $77,000 | +37.5% | 18,054 | +45.9% | 0.00% | – |
| Q2 2022 | $56,000 | -35.6% | 12,373 | -20.8% | 0.00% | – |
| Q1 2022 | $87,000 | +14.5% | 15,614 | +27.9% | 0.00% | – |
| Q4 2021 | $76,000 | -41.5% | 12,204 | -7.3% | 0.00% | – |
| Q3 2021 | $130,000 | -25.3% | 13,168 | -32.4% | 0.00% | – |
| Q2 2021 | $174,000 | -12.6% | 19,491 | +8.3% | 0.00% | – |
| Q1 2021 | $199,000 | +9850.0% | 17,991 | +8895.5% | 0.00% | – |
| Q4 2020 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |